Venessa Tan, MD, MPH
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,459 | 327 | 99.8% |
| Education | $10.66 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,301 | 71 | $0 (2020) |
| Novo Nordisk Inc | $608.95 | 57 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $423.65 | 53 | $0 (2020) |
| GlaxoSmithKline, LLC. | $379.64 | 27 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $247.57 | 18 | $0 (2020) |
| Astellas Pharma US Inc | $192.38 | 12 | $0 (2020) |
| Abbott Laboratories | $177.01 | 10 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.94 | 9 | $0 (2019) |
| PFIZER INC. | $123.63 | 10 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $109.18 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $41.53 | 2 | Abbott Laboratories ($41.53) |
| 2021 | $27.52 | 2 | GlaxoSmithKline, LLC. ($14.13) |
| 2020 | $811.62 | 55 | AstraZeneca Pharmaceuticals LP ($391.25) |
| 2019 | $1,270 | 91 | AstraZeneca Pharmaceuticals LP ($400.18) |
| 2018 | $1,283 | 99 | AstraZeneca Pharmaceuticals LP ($303.55) |
| 2017 | $1,036 | 80 | AstraZeneca Pharmaceuticals LP ($206.28) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Neuromodulation | ||||||
| 07/10/2023 | Abbott Laboratories | PRODIGY (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Neuromodulation | ||||||
| 08/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: VACCINES | ||||||
| 11/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 11/17/2020 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Respiratory | ||||||
| 11/05/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: UROLOGY | ||||||
| 11/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 10/13/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Respiratory | ||||||
| 10/07/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes | ||||||
| 09/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/02/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 08/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Endocrinology | ||||||
| 07/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 07/29/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/14/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 318 | 511 | $144,685 | $46,916 |
| 2022 | 8 | 441 | 901 | $209,010 | $66,461 |
| 2021 | 10 | 494 | 859 | $210,185 | $69,650 |
| 2020 | 20 | 873 | 1,282 | $157,101 | $71,352 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 173 | $20,705 | $8,998 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 58 | 140 | $18,628 | $8,414 | 45.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 22 | $8,495 | $3,724 | 43.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 29 | 36 | $7,270 | $3,124 | 43.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 18 | 20 | $6,508 | $3,090 | 47.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 42 | 45 | $4,120 | $1,956 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 16 | 16 | $2,864 | $1,941 | 67.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 22 | $4,038 | $1,920 | 47.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 25 | 25 | $3,449 | $1,889 | 54.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $5,550 | $1,878 | 33.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 24 | 49 | $2,989 | $1,621 | 54.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 133 | 133 | $2,185 | $1,461 | 66.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 22 | 22 | $1,848 | $1,342 | 72.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 14 | $1,839 | $852.61 | 46.4% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 15 | 22 | $1,601 | $717.51 | 44.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 35 | 54 | $1,236 | $505.59 | 40.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 28 | 29 | $830.00 | $496.62 | 59.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 49 | 74 | $522.00 | $255.21 | 48.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 12 | $330.00 | $141.95 | 43.0% |
About Venessa Tan, MD, MPH
Venessa Tan, MD, MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780845669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Venessa Tan, MD, MPH has received a total of $4,469 in payments from pharmaceutical and medical device companies, with $41.53 received in 2023. These payments were reported across 329 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,459).
As a Medicare-enrolled provider, Tan has provided services to 2,126 Medicare beneficiaries, totaling 3,553 services with total Medicare billing of $254,380. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Stony Brook, NY
- Active Since 06/23/2008
- Last Updated 11/18/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780845669
Products in Payments
- FARXIGA (Drug) $1,085
- XARELTO (Drug) $390.07
- Ozempic (Drug) $223.14
- TOUJEO (Drug) $178.97
- TRELEGY ELLIPTA (Drug) $169.30
- XIFAXAN (Drug) $152.06
- Saxenda (Drug) $130.70
- Victoza (Drug) $121.95
- AFREZZA (Drug) $106.97
- JARDIANCE (Drug) $104.76
- Myrbetriq (Drug) $94.98
- Prolia (Biological) $80.58
- FreeStyle Libre (Device) $75.26
- PNEUMOVAX 23 (Biological) $73.19
- Tresiba (Drug) $68.99
- ADVAIR (Drug) $65.91
- MYRBETRIQ (Drug) $64.29
- BYDUREON (Drug) $63.01
- CHANTIX (Drug) $61.71
- ENTRESTO (Drug) $58.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Stony Brook
Noreen Bukhari-Parlakturk, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $26,258
Aadit Shah, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18,802
Kristine Jang, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $18,437
Mr. Stuart Drew
Student in an Organized Health Care Education/Training Program — Payments: $10,662
Dr. Brian Mccormack, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $9,541
Sonya Marcus, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,616